We’ve recently updated our valuation analysis.

Huntington Bancshares Valuation

Is HBAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score

3/6

Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HBAN?

Other financial metrics that can be useful for relative valuation.

HBAN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ratio3x

Price to Earnings Ratio vs Peers

How does HBAN's PE Ratio compare to its peers?

The above table shows the PE ratio for HBAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average12.1x
FRC First Republic Bank
15.1x10.2%US$23.1b
RF Regions Financial
11.4x4.0%US$21.6b
CFG Citizens Financial Group
11.2x11.1%US$20.5b
FITB Fifth Third Bancorp
10.7x6.5%US$24.2b
HBAN Huntington Bancshares
11.8x3.9%US$22.3b

Price-To-Earnings vs Peers: HBAN is good value based on its Price-To-Earnings Ratio (11.8x) compared to the peer average (12.1x).


Price to Earnings Ratio vs Industry

How does HBAN's PE Ratio compare vs other companies in the US Banks Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a8.0%
n/an/an/a

Price-To-Earnings vs Industry: HBAN is expensive based on its Price-To-Earnings Ratio (11.8x) compared to the US Banks industry average (10x)


Price to Earnings Ratio vs Fair Ratio

What is HBAN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HBAN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.8x
Fair PE Ratio11.5x

Price-To-Earnings vs Fair Ratio: HBAN is expensive based on its Price-To-Earnings Ratio (11.8x) compared to the estimated Fair Price-To-Earnings Ratio (11.5x).


Share Price vs Fair Value

What is the Fair Price of HBAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HBAN ($15.46) is trading below our estimate of fair value ($30.15)

Significantly Below Fair Value: HBAN is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HBAN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$15.46
US$16.06
+3.8%
8.4%US$18.00US$13.00n/a18
Nov ’23US$15.28
US$15.83
+3.6%
9.2%US$18.00US$12.00n/a18
Oct ’23US$13.18
US$14.97
+13.6%
9.7%US$17.00US$11.00n/a18
Sep ’23US$13.37
US$15.00
+12.2%
10.1%US$17.00US$11.00n/a18
Aug ’23US$13.35
US$15.00
+12.4%
10.1%US$17.00US$11.00n/a18
Jul ’23US$12.10
US$15.89
+31.3%
12.8%US$20.00US$11.00n/a18
Jun ’23US$13.59
US$16.50
+21.4%
11.5%US$20.00US$11.00n/a18
May ’23US$13.15
US$16.94
+28.9%
7.9%US$20.00US$14.50n/a18
Apr ’23US$14.44
US$17.75
+22.9%
6.1%US$20.00US$16.00n/a18
Mar ’23US$14.39
US$17.85
+24.1%
6.1%US$20.00US$16.00n/a17
Feb ’23US$15.56
US$17.91
+15.1%
5.9%US$20.00US$16.00n/a17
Jan ’23US$15.42
US$17.81
+15.5%
6.0%US$20.00US$16.00n/a18
Dec ’22US$14.66
US$17.78
+21.3%
5.7%US$20.00US$16.00US$15.5918
Nov ’22US$15.95
US$17.61
+10.4%
7.4%US$20.00US$15.00US$15.2818
Oct ’22US$15.86
US$17.24
+8.7%
8.3%US$20.00US$15.00US$13.1818
Sep ’22US$15.32
US$17.18
+12.1%
8.1%US$20.00US$15.00US$13.3718
Aug ’22US$14.08
US$17.18
+22.0%
8.1%US$20.00US$15.00US$13.3517
Jul ’22US$14.43
US$17.44
+20.8%
7.4%US$19.00US$15.00US$12.1016
Jun ’22US$16.08
US$17.56
+9.2%
7.3%US$20.00US$15.00US$13.5916
May ’22US$15.32
US$17.29
+12.9%
8.4%US$20.00US$14.00US$13.1518
Apr ’22US$15.98
US$17.08
+6.9%
9.4%US$20.00US$14.50US$14.4418
Mar ’22US$15.83
US$15.74
-0.6%
8.7%US$18.00US$13.00US$14.3918
Feb ’22US$13.22
US$15.57
+17.8%
8.9%US$18.00US$13.00US$15.5618
Jan ’22US$12.63
US$13.42
+6.2%
12.6%US$16.50US$10.50US$15.4218
Dec ’21US$12.50
US$11.87
-5.1%
7.3%US$14.00US$10.50US$14.6619

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies